+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ignyta  - logo

Ignyta is an oncology biotechnology company. The company focuses on integrated therapeutic (Rx) and companion diagnostic (Dx) strategies for treating cancer patients. Its Rx is focused on developing molecularly targeted therapies for eradicating residual disease. Its Dx focuses on pairing the product candidates with biomarker-based companion diagnostics that are designed to identify the patients who will benefit from the therapies it develops. The company was founded in 2011 and is headquartered in San Diego, California.

From
From
From
From
Cancer Stem Cell Therapies Market, 2017-2030 - Product Thumbnail Image

Cancer Stem Cell Therapies Market, 2017-2030

  • Report
  • December 2017
  • 270 Pages
From
From
Papillary Thyroid Cancer - Pipeline Insight, 2020 - Product Thumbnail Image

Papillary Thyroid Cancer - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
From
From
From
Tyrosine Protein Kinase Mer - Pipeline Review, H1 2020 - Product Thumbnail Image

Tyrosine Protein Kinase Mer - Pipeline Review, H1 2020

  • Drug Pipelines
  • February 2020
  • 69 Pages
From
Tyrosine Protein Kinase Receptor TYRO3 - Pipeline Review, H2 2019 - Product Thumbnail Image

Tyrosine Protein Kinase Receptor TYRO3 - Pipeline Review, H2 2019

  • Drug Pipelines
  • November 2019
  • 40 Pages
From
From
From
From
Loading Indicator
adroll